Emerging Areas in Diagnosis
The tools below are under study for use in breast cancer diagnosis. They may give information about tumors that can help guide treatment.
Our commitment to research
At Susan G. Komen®, we are committed to saving lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer. Our Research Program our continuing investment in research is an essential driving force for achieving this mission.
Since our inception in 1982, Komen has provided funding to support research grants that have greatly expanded our knowledge of breast cancer and helped us understand that breast cancer is not just a single disease but many diseases, unique to each individual.
To date, Komen has provided nearly $1.1 billion to researchers in 47 states, the District of Columbia and 24 countries to support research that has resulted in a better understanding of breast cancer; earlier detection; personalized, less invasive treatments for what was once a “one-treatment-fits-all” disease; and improvements in both quality of life and survival rates.
Learn more about our continuing investment in research and the exciting research that we are funding, because nothing would make us happier than ending breast cancer forever.
Susan G. Komen research spotlight
Komen-funded research led by Dr. Daniel Stover is using liquid biopsy, a blood test that looks for circulating tumor cells or pieces of DNA from tumor cells, to improve breast cancer treatment in the clinic.
Learn more in our blog, Dr. Daniel Stover Leverages Lab Learnings to Improve His Patients’ Care.